SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Bambusa Therapeutics Sees IPO of 9,375,000 Common Shares

An SEC filing indicates Bambusa Therapeutics expects an IPO of 9,375,000 common shares.

Related stories